Sotabase

Career

· PhD Student, MIT Julia Lab2022–
· Researcher, MIT-Harvard Center for Ultracold Atoms (CUA)2017–2023

Publications (53)

The integration of immune checkpoint inhibitors with VEGF targeted agents in advanced gastric and gastroesophageal adenocarcinoma: a review on the rationale and results of early phase trials
Journal of Hematology & Oncology · 2021
75
cited
Treatment-Related Adverse Events of Combination Immune Checkpoint Inhibitors: Systematic Review and Meta-Analysis
Frontiers in Oncology · 2020
64
cited
Immune Therapeutics in the Treatment of Advanced Gastric and Esophageal Cancer
Anticancer Research · 2018
46
cited
Anti-PD-1/L1-associated immune-related adverse events as harbinger of favorable clinical outcome: systematic review and meta-analysis
Clinical and Translational Oncology · 2020
37
cited
Association of active oncologic treatment and risk of death in cancer patients with COVID-19: a systematic review and meta-analysis of patient data
Acta oncologica · 2020
37
cited
Sex-bias in COVID-19-associated illness severity and mortality in cancer patients: A systematic review and meta-analysis
EClinicalMedicine · 2020
32
cited
Biologics, Immunotherapy, and Future Directions in the Treatment of Advanced Cholangiocarcinoma.
Clinical colorectal cancer · 2019
31
cited
Cabozantinib plus durvalumab in advanced gastroesophageal cancer and other gastrointestinal malignancies: Phase Ib CAMILLA trial results
Cell Reports Medicine · 2023
29
cited
Immuno-Oncotherapeutic Approaches in Advanced Hepatocellular Carcinoma
Vaccines · 2020
26
cited
GSK-3β in Pancreatic Cancer: Spotlight on 9-ING-41, Its Therapeutic Potential and Immune Modulatory Properties
Biology · 2021
23
cited
Immunotherapy in Colorectal Cancer: Potential of Fecal Transplant and Microbiota-Augmented Clinical Trials
Current Colorectal Cancer Reports · 2020
22
cited
Outcomes following immunotherapy re-challenge after immune-related adverse event: systematic review and meta-analysis.
Immunotherapy · 2020
21
cited
Immunotherapy Predictive Molecular Markers in Advanced Gastroesophageal Cancer: MSI and Beyond
Cancers · 2021
20
cited
Trends, variation, and clinical characteristics of recipients of antiviral drugs and neutralising monoclonal antibodies for covid-19 in community settings: retrospective, descriptive cohort study of 23.4 million people in OpenSAFELY
BMJ Medicine · 2023
19
cited
Phase II trial of cabozantinib (Cabo) plus durvalumab (Durva) in chemotherapy refractory patients with advanced mismatch repair proficient/microsatellite stable (pMMR/MSS) colorectal cancer (CRC): CAMILLA CRC cohort results.
Journal of Clinical Oncology · 2022
18
cited
Increased risk of acute kidney injury in coronavirus disease patients with renin–angiotensin–aldosterone-system blockade use: a systematic review and meta-analysis
Scientific Reports · 2021
16
cited
Advances in immune therapies for the treatment of microsatellite instability-high/deficient mismatch repair metastatic colorectal cancer (Review)
International Journal of Oncology · 2021
12
cited
Comparison of Efficacy of Systemic Therapies in Advanced Hepatocellular Carcinoma: Updated Systematic Review and Frequentist Network Meta-Analysis of Randomized Controlled Trials
Journal of Hepatocellular Carcinoma · 2021
12
cited
Comparative Efficacy and Safety of Programmed Death-1 Pathway Inhibitors in Advanced Gastroesophageal Cancers: A Systematic Review and Network Meta-Analysis of Phase III Clinical Trials
Cancers · 2021
11
cited
Promising Novel Biomarkers for Hepatocellular Carcinoma: Diagnostic and Prognostic Insights
Journal of Hepatocellular Carcinoma · 2023
11
cited
Sotabase
Robin Park | Researcher Profile | Sotabase | Sotabase